Michael S. Okun | |
---|---|
Born | July 5, 1971 |
Academic background | |
Education | Florida State University (B.S.)
University of Florida (M.D., Residency) Emory University (Fellowship) [1] |
Academic work | |
Institutions | University of Florida |
Michael S. Okun (born July 5, 1971) is an American neurologist, neuroscientist and author. He is the co-founder and director of the Norman Fixel Institute for Neurological Diseases at University of Florida Health [2] and is also the chair of the Department of Neurology at the University of Florida and the Medical Director/Advisor for the Parkinson's Foundation. [2] He is the fifth person at the University's College of Medicine to hold the rank of Distinguished Professor. [3]
Okun opened his laboratory in 2002 at the McKnight Brain Institute on the University of Florida Campus. The laboratory focused on uncovering the underpinnings of human tic in Tourette syndrome, exploring non-motor basal ganglia circuitry in Parkinson’s disease, Tourette, dystonia, OCD and tremor and the aim of the laboratory was to innovate neuromodulation and circuit-based treatments for multiple neurological and neuropsychiatric diseases. [4]
Okun recognized that some diseases lacked animal models which would recapitulate the human condition(s). He advocated and implemented a neuroethics-based approach to utilize the operating room and the outpatient clinic setting for research into these neurological conditions. The Okun laboratory originally focused on Tourette syndrome because of the paroxysmal nature of human tic, which made it ideal to explore the physiological underpinnings of the movement disorder. [5] His work has been important in understanding the biological changes underpinning the neural network changes which underpin the symptomatic benefits of deep brain stimulation and for moving toward symptom and circuit based treatments rather than disease based treatments. Okun has trained over 70 clinical MD fellows and many researchers in basal ganglia and related disorders. [6]
Okun, Foote and Gunduz were featured on an episode of Vital Signs with CNN's Sanjay Gupta, who scrubbed in to the operating room with the team and explored their approach to innovating new therapies for Tourette syndrome. [7]
Okun and the University of Florida based group performed a series of National Institutes of Health, foundation and philanthropically funded experiments between 2002 and 2022 that resulted in the successful characterization of human tic physiology.[ citation needed]
Okun designed and carried out one of the first large prospective randomized Parkinson’s disease trials comparing the two most common DBS brain targets. The study, known as the NIH COMPARE trial, revealed unilateral STN or GPi DBS resulted in similar motor benefits, however there were important advantages and disadvantages for using each brain target. [8]
Okun has been recognized as the top clinical-researcher at the University of Florida College of Medicine (2021) and he was also recognized in a 2015 White House ceremony by the Obama administration as a Champion of Change for Parkinson's Disease. [9]
Okun's first book as an author was Lessons from the Bedside which this was published in 1995 as a book of prose and poetry which chronicled the medical school experience. He was interviewed for the PBS series Healing Words (2008) which focused on poetry in medicine.
Okun has been published in the New England Journal of Medicine, Lancet, and the Journal of the American Medical Association. [10] He has authored or co-authored 14 books[ citation needed] and hundreds of research articles. [11]
{{
cite journal}}
: Cite journal requires |journal=
(
help)
Michael S. Okun | |
---|---|
Born | July 5, 1971 |
Academic background | |
Education | Florida State University (B.S.)
University of Florida (M.D., Residency) Emory University (Fellowship) [1] |
Academic work | |
Institutions | University of Florida |
Michael S. Okun (born July 5, 1971) is an American neurologist, neuroscientist and author. He is the co-founder and director of the Norman Fixel Institute for Neurological Diseases at University of Florida Health [2] and is also the chair of the Department of Neurology at the University of Florida and the Medical Director/Advisor for the Parkinson's Foundation. [2] He is the fifth person at the University's College of Medicine to hold the rank of Distinguished Professor. [3]
Okun opened his laboratory in 2002 at the McKnight Brain Institute on the University of Florida Campus. The laboratory focused on uncovering the underpinnings of human tic in Tourette syndrome, exploring non-motor basal ganglia circuitry in Parkinson’s disease, Tourette, dystonia, OCD and tremor and the aim of the laboratory was to innovate neuromodulation and circuit-based treatments for multiple neurological and neuropsychiatric diseases. [4]
Okun recognized that some diseases lacked animal models which would recapitulate the human condition(s). He advocated and implemented a neuroethics-based approach to utilize the operating room and the outpatient clinic setting for research into these neurological conditions. The Okun laboratory originally focused on Tourette syndrome because of the paroxysmal nature of human tic, which made it ideal to explore the physiological underpinnings of the movement disorder. [5] His work has been important in understanding the biological changes underpinning the neural network changes which underpin the symptomatic benefits of deep brain stimulation and for moving toward symptom and circuit based treatments rather than disease based treatments. Okun has trained over 70 clinical MD fellows and many researchers in basal ganglia and related disorders. [6]
Okun, Foote and Gunduz were featured on an episode of Vital Signs with CNN's Sanjay Gupta, who scrubbed in to the operating room with the team and explored their approach to innovating new therapies for Tourette syndrome. [7]
Okun and the University of Florida based group performed a series of National Institutes of Health, foundation and philanthropically funded experiments between 2002 and 2022 that resulted in the successful characterization of human tic physiology.[ citation needed]
Okun designed and carried out one of the first large prospective randomized Parkinson’s disease trials comparing the two most common DBS brain targets. The study, known as the NIH COMPARE trial, revealed unilateral STN or GPi DBS resulted in similar motor benefits, however there were important advantages and disadvantages for using each brain target. [8]
Okun has been recognized as the top clinical-researcher at the University of Florida College of Medicine (2021) and he was also recognized in a 2015 White House ceremony by the Obama administration as a Champion of Change for Parkinson's Disease. [9]
Okun's first book as an author was Lessons from the Bedside which this was published in 1995 as a book of prose and poetry which chronicled the medical school experience. He was interviewed for the PBS series Healing Words (2008) which focused on poetry in medicine.
Okun has been published in the New England Journal of Medicine, Lancet, and the Journal of the American Medical Association. [10] He has authored or co-authored 14 books[ citation needed] and hundreds of research articles. [11]
{{
cite journal}}
: Cite journal requires |journal=
(
help)